← Back to Search

Behavioral Relaxation Approaches for Lung Cancer (LC_ART Trial)

N/A
Waitlist Available
Research Sponsored by University of Pennsylvania
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
18 or older
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 14 days
Awards & highlights
No Placebo-Only Group

Summary

This trial is studying two mindfulness interventions to help improve sleep quality and anxiety in lung cancer patients. 20 patients with insomnia will be enrolled and will use a behavioral intervention.

Who is the study for?
This trial is for lung cancer patients over 18 who are experiencing insomnia, whether in remission or undergoing certain chemotherapies. Participants need internet at home, access to a smartphone, and must be more than 4 weeks post-surgery and fluent in English.
What is being tested?
The study compares two types of simplified mindfulness techniques designed to help improve sleep quality and reduce anxiety related to sleep issues in lung cancer patients. It's a randomized study lasting for 30 days with participants using behavioral interventions.
What are the potential side effects?
Since the interventions involve assisted relaxation therapy and modified versions of it, side effects may include discomfort with the process or frustration if immediate improvements in sleep aren't experienced.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 18 years old or older.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~14 days
This trial's timeline: 3 weeks for screening, Varies for treatment, and 14 days for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change from Baseline Sleep Onset Latency at 14 days

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Group I: Modified Assisted Relaxation TherapyExperimental Treatment2 Interventions
This group will be receiving a modified version of an assisted relaxation therapy intervention
Group II: Assisted Relaxation TherapyExperimental Treatment1 Intervention
This group will be receiving an assisted relaxation therapy intervention

Find a Location

Who is running the clinical trial?

University of PennsylvaniaLead Sponsor
2,078 Previous Clinical Trials
42,721,365 Total Patients Enrolled
15 Trials studying Insomnia
4,777 Patients Enrolled for Insomnia
Abramson Cancer Center of the University of PennsylvaniaLead Sponsor
359 Previous Clinical Trials
108,484 Total Patients Enrolled
Abramson Cancer Center at Penn MedicineLead Sponsor
413 Previous Clinical Trials
164,611 Total Patients Enrolled

Media Library

Assisted Relaxation Therapy Clinical Trial Eligibility Overview. Trial Name: NCT04318249 — N/A
Insomnia Research Study Groups: Assisted Relaxation Therapy, Modified Assisted Relaxation Therapy
Insomnia Clinical Trial 2023: Assisted Relaxation Therapy Highlights & Side Effects. Trial Name: NCT04318249 — N/A
Assisted Relaxation Therapy 2023 Treatment Timeline for Medical Study. Trial Name: NCT04318249 — N/A
~9 spots leftby Apr 2026
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top